Changfu Wei serves as a Senior Manager at Thermo Fisher Scientific, where he leverages his extensive expertise in molecular assays and immunoassay development to drive innovation in genetic testing solutions. With a robust background in method development, process verification, and validation, Changfu plays a pivotal...
Changfu Wei serves as a Senior Manager at Thermo Fisher Scientific, where he leverages his extensive expertise in molecular assays and immunoassay development to drive innovation in genetic testing solutions. With a robust background in method development, process verification, and validation, Changfu plays a pivotal role in the advancement of in vitro diagnostic (IVD) products, including CE-IVD and Research Use Only (RUO) offerings. His hands-on experience with cutting-edge technologies such as quantitative PCR (qPCR), reverse transcription PCR (RT-PCR), and massive multiplex PCR (mmPCR) positions him as a key contributor to the development of high-throughput testing platforms, including the Open Array and TaqMan Array Card.
Changfu's leadership in syndromic testing and microbial gene identification projects underscores his commitment to enhancing diagnostic accuracy and efficiency. His proficiency in next-generation sequencing (NGS) techniques, coupled with a strong foundation in Sanger sequencing and Multiplex Ligation-dependent Probe Amplification (MLPA), enables him to spearhead complex projects that require meticulous attention to detail and rigorous validation processes.
In addition to his technical skills, Changfu is adept at technology transfer and production support, ensuring that innovative solutions transition seamlessly from the lab to clinical application. His contributions not only enhance the capabilities of Thermo Fisher Scientific but also advance the broader life sciences field, ultimately improving patient outcomes through more precise and reliable genetic testing methodologies. With a focus on continuous process improvement, Changfu Wei exemplifies the intersection of scientific expertise and leadership in the rapidly evolving landscape of molecular diagnostics.
